Terns Pharmaceuticals' Series A Round

Terns Pharmaceuticals raised a round of funding on April 04, 2018. Investors include Lilly Asia Ventures.

Terns Pharmaceuticals is a global biopharmaceutical company committed to discovering and developing molecularly-targeted, oral, small molecule drugs to treat liver disease and cancer.…

Articles about Terns Pharmaceuticals' Series A Round: